XPH ETF
State Street SPDR S&P Pharmaceuticals ETF
CRNX is XPH's largest holding at 3.61% of the fund as of Aug 4, 2026. XPH is State Street SPDR S&P Pharmaceuticals ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Sector | Industry |
|---|---|---|---|---|---|---|---|
| 1 |  C | Crinetics Pharmaceuticals IncHealth Care · Pharmaceuticals | 3.61% | 3.6% | 217,460 | Health Care | Pharmaceuticals |
| 2 |  M | Mbx Biosciences IncHealth Care · Biotechnology | 3.37% | 7.0% | 240,830 | Health Care | Biotechnology |
| Sector and industry · Pro | |||||||
| 3 | — | Ataibeckley Inc. | 2.80% | 9.8% | 1,974,411 | ||
| 4 | — | Definium Therapeutics, Inc. Common Shares | 2.69% | 12.5% | 321,139 | ||
| 5 |  E | Enliven Therapeutics Inc | 2.44% | 14.9% | 201,711 | ||
| 6 |  A | Amylyx Pharmaceuticals Inc | 2.40% | 17.3% | 554,478 | ||
| 7 |  C | Corcept Therapeutics Inc | 2.08% | 19.4% | 95,538 | ||
| 8 |  N | Nuvation Bio Inc | 2.08% | 21.5% | 1,629,536 | ||
| 9 |  T | Trevi Therapeutics Inc. | 2.07% | 23.5% | 556,960 | ||
| 10 |  E | Edgewise Therapeutics Inc. | 2.01% | 25.5% | 226,709 | ||
| 11 |  A | Alumis Inc | 2.00% | 27.5% | 372,046 | ||
| 12 | — | Liquidia Technologies Inc | 2.00% | 29.5% | 114,381 | ||
| 13 |  N | Nektar Therapeutics Class A | 1.89% | 31.4% | 131,439 | ||
| 14 |  O | Omeros Corp | 1.87% | 33.3% | 731,692 | ||
| 15 |  L | Ligand Pharmaceuticals, Inc. | 1.79% | 35.1% | 30,068 | ||
| 16 |  A | Amneal Pharmaceuticals Inc. | 1.78% | 36.9% | 487,157 | ||
| 17 |  B | Bristol-Myers Squibb Co. | 1.75% | 38.6% | 134,232 | ||
| 18 | — | Pacira Pharm Inc | 1.74% | 40.4% | 318,671 | ||
| 19 |  M | Veradermics Inc | 1.70% | 42.1% | 80,267 | ||
| 20 |  J | Jazz Pharmaceuticals Plc. | 1.68% | 43.8% | 32,499 | ||
| 21 |  M | Maze Therapeutics Inc | 1.66% | 45.4% | 303,458 | ||
| 22 |  V | Viatris Inc. | 1.66% | 47.1% | 473,256 | ||
| 23 |  E | Elanco Animal Health, Inc Cvr | 1.65% | 48.7% | 326,334 | ||
| 24 | — | Harrow Health Inc | 1.64% | 50.4% | 207,890 | ||
| 25 |  H | Harmony Biosciences, Llc | 1.61% | 52.0% | 210,351 | ||
| 26 |  E | Eton Pharmaceuticals Inc. | 1.60% | 53.6% | 176,293 | ||
| 27 |  M | Merck & Company Inc | 1.59% | 55.2% | 62,672 | ||
| 28 |  J | Johnson & Johnson - | 1.58% | 56.7% | 31,294 | ||
| 29 |  W | Wave Life Sciences Ltd | 1.57% | 58.3% | 1,318,599 | ||
| 30 |  P | Prestige Consumer Healthcare Inc | 1.56% | 59.9% | 151,909 | ||
| 31 |  R | Royalty Pharma Plc Class A Ordinary Share | 1.56% | 61.4% | 136,891 | ||
| 32 |  C | Collegium Pharmaceutical Inc | 1.52% | 63.0% | 214,464 | ||
| 33 |  O | Organon & Co | 1.50% | 64.5% | 557,794 | ||
| 34 |  P | Pfizer Inc | 1.47% | 65.9% | 291,536 | ||
| 35 |  T | Tarsus Pharmaceuticals Inc | 1.47% | 67.4% | 121,810 | ||
| 36 |  L | Eli Lilly & Co. | 1.45% | 68.8% | 6,565 | ||
| 37 |  O | Ocular Therapeutix Inc | 1.45% | 70.3% | 853,921 | ||
| 38 |  P | Phibro Animal Health Corp | 1.45% | 71.7% | 200,010 | ||
| 39 |  A | Ani Pharmaceuticals Inc | 1.43% | 73.2% | 91,179 | ||
| 40 |  S | Supernus Pharmaceuticals Inc | 1.42% | 74.6% | 165,520 | ||
| 41 |  P | Perrigo Company Plc Ordinary Shares | 1.42% | 76.0% | 668,156 | ||
| 42 | — | Indivior Pharmaceuticals, Inc. Ordinary Shares | 1.41% | 77.4% | 195,939 | ||
| 43 |  R | Rapport Therapeutics, Inc. | 1.41% | 78.8% | 168,780 | ||
| 44 |  E | Eyepoint Pharmaceuticals Inc.(eypt) | 1.40% | 80.2% | 605,296 | ||
| 45 | — | Xeris Pharmaceuticals Inc | 1.39% | 81.6% | 859,942 | ||
| 46 |  Z | Zoetis Inc, Class A | 1.38% | 83.0% | 91,812 | ||
| 47 |  I | Innoviva Inc | 1.34% | 84.3% | 324,490 | ||
| 48 |  A | Arvinas Inc | 1.31% | 85.7% | 733,945 | ||
| 49 |  A | Axsome Therapeutics Inc | 1.27% | 86.9% | 30,296 | ||
| 50 |  A | Alto Neuroscience, Inc., Series C | 1.21% | 88.1% | 217,132 | ||
| More holdings · Pro | |||||||
XPH ETF All Holdings
XPH holdings total 67 positions. The top 10 holdings account for 25.5% of the fund, led by Crinetics Pharmaceuticals Inc Com at 3.6%, Mbx Biosciences Inc at 3.4%, Ataibeckley Inc. at 2.8%.
XPH portfolio concentration is well-diversified, with the top 10 representing 25.5% of total assets. The largest sector exposure is Health Care at 84.6%.
XPH sectors provide a detailed breakdown. XPH overlap shows how holdings compare to other funds in your portfolio.
XPH ETF Holdings
67 of 67 holdings
- 1
Crinetics Pharmaceuticals Inc Com
CRNXHealth Care3.61% - 2
Mbx Biosciences Inc
MBXHealth Care3.37% - 3
Ataibeckley Inc.
ATAIHealth Care2.80% - 4
Definium Therapeutics, Inc. Common Shares
DFTX:CAUnknown2.69% - 5
Enliven Therapeutics Inc
ELVNHealth Care2.44% - 6
Amylyx Pharmaceuticals Inc
AMLXHealth Care2.40% - 7
Corcept Therapeutics Incorporated
CORTHealth Care2.08% - 8
Nuvation Bio Inc
NUVBHealth Care2.08% - 9
Trevi Therapeutics Inc.
TRVIHealth Care2.07% - 10
Edgewise Therapeutics Inc.
EWTXHealth Care2.01% - 11
Alumis Inc Common Stock USD 0.0001
ALMSIndustrials2.00% - 12
Liquidia Technologies Inc
LQDAHealth Care2.00% - 13
Nektar Therapeutics Class A
NKTRUnknown1.89% - 14
Omeros Corp Com
OMERHealth Care1.87% - 15
Ligand Pharmaceuticals, Inc.
LGNDHealth Care1.79% - 16
Amneal Pharmaceuticals Inc.
AMRXHealth Care1.78% - 17
Bristol-Myers Squibb Co.
BMYHealth Care1.75% - 18
Pacira Pharm Inc
PCRXHealth Care1.74% - 19
Veradermics Inc
MANEUnknown1.70% - 20
Jazz Pharmaceuticals Plc.
JAZZHealth Care1.68% - 21
Maze Therapeutics Inc
MAZEHealth Care1.66% - 22
Viatris Inc.
VTRSHealth Care1.66% - 23
Elanco Animal Health, Inc Cvr
ELANHealth Care1.65% - 24
Harrow Health Inc Com
HROWHealth Care1.64% - 25
Harmony Biosciences, Llc
HRMYHealth Care1.61% - 26
Eton Pharmaceuticals Inc.
ETONHealth Care1.60% - 27
Merck & Company Inc
MRKHealth Care1.59% - 28
Johnson & Johnson - Common
JNJHealth Care1.58% - 29
Wave Life Sciences Ltd
WVEHealth Care1.57% - 30
Prestige Consumer Healthcare Inc
PBHConsumer Staples1.56% - 31
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials1.56% - 32
Collegium Pharmaceutical Inc
COLLHealth Care1.52% - 33
Organon & Co
OGNHealth Care1.50% - 34
Pfizer Inc
PFEHealth Care1.47% - 35
Tarsus Pharmaceuticals Inc
TARSHealth Care1.47% - 36
Eli Lilly & Co.
LLYHealth Care1.45% - 37
Ocular Therapeutix Inc
OCULHealth Care1.45% - 38
Phibro Animal Health Corp
PAHCHealth Care1.45% - 39
Ani Pharmaceuticals Inc
ANIPHealth Care1.43% - 40
Supernus Pharmaceuticals Inc
SUPNHealth Care1.42% - 41
Perrigo Company Plc Ordinary Shares
PRGOConsumer Staples1.42% - 42
Indivior Pharmaceuticals, Inc. Ordinary Shares
INDV:MBUnknown1.41% - 43
Rapport Therapeutics, Inc.
RAPPHealth Care1.41% - 44
Eyepoint Pharmaceuticals Inc.(eypt)
EYPTHealth Care1.40% - 45
Xeris Pharmaceuticals Inc Com
XERSHealth Care1.39% - 46
Zoetis Inc, Class A
ZTSHealth Care1.38% - 47
Innoviva Inc
INVAHealth Care1.34% - 48
Arvinas Inc
ARVNHealth Care1.31% - 49
Axsome Therapeutics Inc
AXSMHealth Care1.27% - 50
Alto Neuroscience, Inc., Series C
ANROHealth Care1.21% - 51
Amphastar Pharmaceuticals Inc
AMPHHealth Care1.19% - 52
Septerna Inc
SEPNHealth Care1.12% - 53
Lb Pharmaceuticals Inc.
LBRXUnknown1.07% - 54
Aclaris Therapeutics Inc
ACRSHealth Care0.98% - 55
Cormedix Inc Com
CRMDHealth Care0.93% - 56
Theravance Biopharma Inc
TBPHHealth Care0.92% - 57
Zevra Therapeutics Inc
ZVRAHealth Care0.88% - 58
Relmada Therapeutics Inc Common Stock
RLMDHealth Care0.81% - 59
Phathom Pharmaceuticals Inc Phat
PHATHealth Care0.80% - 60
Fulcrum Therapeutics Inc Com
FULCHealth Care0.69% - 61
Ara Us Hospitality Trust
AQSTHealth Care0.67% - 62
Bioage Labs Inc Common Stock Usd.00001
BIOAHealth Care0.66% - 63
Lexicon Pharmaceut Com New
LXRXHealth Care0.63% - 64
Evolus Inc
EOLSHealth Care0.45% - 65
Ssi Us Gov Money Market Class
NMFUnknown0.09% - 66
Contra Esperion Therap
Other0.01% - 67
US Dollar
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Crinetics Pharmaceuticals Inc Com | CRNX | 3.610% | ||
| 2 | Mbx Biosciences Inc | MBX | 3.370% | ||
| 3 | Ataibeckley Inc. | ATAI | 2.800% | ||
| 4 | Definium Therapeutics, Inc. Common Shares | DFTX:CA | 2.690% | ||
| 5 | Enliven Therapeutics Inc | ELVN | 2.440% | ||
| 6 | Amylyx Pharmaceuticals Inc | AMLX | 2.400% | ||
| 7 | Corcept Therapeutics Incorporated | CORT | 2.080% | ||
| 8 | Nuvation Bio Inc | NUVB | 2.080% | ||
| 9 | Trevi Therapeutics Inc. | TRVI | 2.070% | ||
| 10 | Edgewise Therapeutics Inc. | EWTX | 2.010% | ||
| 11 | Alumis Inc Common Stock USD 0.0001 | ALMS | 2.000% | ||
| 12 | Liquidia Technologies Inc | LQDA | 2.000% | ||
| 13 | Nektar Therapeutics Class A | NKTR | 1.890% | ||
| 14 | Omeros Corp Com | OMER | 1.870% | ||
| 15 | Ligand Pharmaceuticals, Inc. | LGND | 1.790% | ||
| 16 | Amneal Pharmaceuticals Inc. | AMRX | 1.780% | ||
| 17 | Bristol-Myers Squibb Co. | BMY | 1.750% | ||
| 18 | Pacira Pharm Inc | PCRX | 1.740% | ||
| 19 | Veradermics Inc | MANE | 1.700% | ||
| 20 | Jazz Pharmaceuticals Plc. | JAZZ | 1.680% | ||
| 21 | Maze Therapeutics Inc | MAZE | 1.660% | ||
| 22 | Viatris Inc. | VTRS | 1.660% | ||
| 23 | Elanco Animal Health, Inc Cvr | ELAN | 1.650% | ||
| 24 | Harrow Health Inc Com | HROW | 1.640% | ||
| 25 | Harmony Biosciences, Llc | HRMY | 1.610% | ||
| 26 | Eton Pharmaceuticals Inc. | ETON | 1.600% | ||
| 27 | Merck & Company Inc | MRK | 1.590% | ||
| 28 | Johnson & Johnson - Common | JNJ | 1.580% | ||
| 29 | Wave Life Sciences Ltd | WVE | 1.570% | ||
| 30 | Prestige Consumer Healthcare Inc | PBH | 1.560% | ||
| 31 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 1.560% | ||
| 32 | Collegium Pharmaceutical Inc | COLL | 1.520% | ||
| 33 | Organon & Co | OGN | 1.500% | ||
| 34 | Pfizer Inc | PFE | 1.470% | ||
| 35 | Tarsus Pharmaceuticals Inc | TARS | 1.470% | ||
| 36 | Eli Lilly & Co. | LLY | 1.450% | ||
| 37 | Ocular Therapeutix Inc | OCUL | 1.450% | ||
| 38 | Phibro Animal Health Corp | PAHC | 1.450% | ||
| 39 | Ani Pharmaceuticals Inc | ANIP | 1.430% | ||
| 40 | Supernus Pharmaceuticals Inc | SUPN | 1.420% | ||
| 41 | Perrigo Company Plc Ordinary Shares | PRGO | 1.420% | ||
| 42 | Indivior Pharmaceuticals, Inc. Ordinary Shares | INDV:MB | 1.410% | ||
| 43 | Rapport Therapeutics, Inc. | RAPP | 1.410% | ||
| 44 | Eyepoint Pharmaceuticals Inc.(eypt) | EYPT | 1.400% | ||
| 45 | Xeris Pharmaceuticals Inc Com | XERS | 1.390% | ||
| 46 | Zoetis Inc, Class A | ZTS | 1.380% | ||
| 47 | Innoviva Inc | INVA | 1.340% | ||
| 48 | Arvinas Inc | ARVN | 1.310% | ||
| 49 | Axsome Therapeutics Inc | AXSM | 1.270% | ||
| 50 | Alto Neuroscience, Inc., Series C | ANRO | 1.210% | ||
| 51 | Amphastar Pharmaceuticals Inc | AMPH | 1.190% | ||
| 52 | Septerna Inc | SEPN | 1.120% | ||
| 53 | Lb Pharmaceuticals Inc. | LBRX | 1.070% | ||
| 54 | Aclaris Therapeutics Inc | ACRS | 0.980% | ||
| 55 | Cormedix Inc Com | CRMD | 0.930% | ||
| 56 | Theravance Biopharma Inc | TBPH | 0.920% | ||
| 57 | Zevra Therapeutics Inc | ZVRA | 0.880% | ||
| 58 | Relmada Therapeutics Inc Common Stock | RLMD | 0.810% | ||
| 59 | Phathom Pharmaceuticals Inc Phat | PHAT | 0.800% | ||
| 60 | Fulcrum Therapeutics Inc Com | FULC | 0.690% | ||
| 61 | Ara Us Hospitality Trust | AQST | 0.670% | ||
| 62 | Bioage Labs Inc Common Stock Usd.00001 | BIOA | 0.660% | ||
| 63 | Lexicon Pharmaceut Com New | LXRX | 0.630% | ||
| 64 | Evolus Inc | EOLS | 0.450% | ||
| 65 | Ssi Us Gov Money Market Class | NMF | 0.090% | ||
| 66 | Contra Esperion Therap | - | 0.010% | ||
| 67 | US Dollar | - | 0.000% |